TrialBMC cancer2026

Memantine to preserve memory and neurocognition following craniospinal irradiation (MEMENTO): a phase 3 randomized controlled trial.

Tejpal Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.